33.35

0.36% -0.12

After Hours: 33.48 0.13 +0.39%

Vtv Therapeutics Inc (VTVT)

Overview News Price History Financials Discussions Forecast

Vtv Therapeutics Inc stock is traded at $33.35, with a volume of 12,064. It is down -0.36% in the last 24 hours and up +4.02% over the past month. vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Previous Close:

$33.47

Open:

$32.97

24h Volume:

12,064

Relative Volume:

0.17

Market Cap:

$131.86M

Revenue:

$36.84M

Net Income/Loss:

$-729.00K

P/E Ratio:

-36.10

EPS:

-0.9237

Net Cash Flow:

$-10.02M

1W Performance:

+3.06%

1M Performance:

+4.02%

6M Performance:

-7.36%

1Y Performance:

+79.88%

1-Day Range:

$32.97

$33.73

1-Week Range:

$31.35

$34.00

52-Week Range:

$18.00

$44.00

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name

Vtv Therapeutics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

336-841-0300

Address

3980 PREMIER DR, HIGH POINT, NC

Employee

Twitter

@vTvTherapeutics

Next Earnings Date

2026-08-11

Latest SEC Filings

VTVT's Discussions on Twitter

Compare VTVT vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VTVT Vtv Therapeutics Inc	33.35	130.80M	36.84M	-729.00K	-10.02M	-0.9237
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Initiated	Evercore ISI	Outperform
Jan-23-26	Initiated	Roth Capital	Buy
Jan-05-26	Initiated	TD Cowen	Buy
Nov-19-25	Initiated	BTIG Research	Buy
May-30-19	Initiated	H.C. Wainwright	Buy
Apr-10-18	Downgrade	Stifel	Buy → Hold
Mar-08-18	Initiated	ROTH Capital	Buy
Feb-08-18	Initiated	Northland Capital	Outperform
Sep-26-16	Initiated	H.C. Wainwright	Buy
Sep-04-15	Initiated	Canaccord Genuity	Buy
Aug-24-15	Initiated	Piper Jaffray	Overweight
Aug-24-15	Initiated	Stifel	Buy

View All

Vtv Therapeutics Inc Stock (VTVT) Latest News

Sep 04, 2026

Responsive Playbooks and the VTVT Inflection - news.stocktradersdaily.com

Sep 04, 2026

Lifesci Capital Upgrades vTv Therapeutics (NASDAQ:VTVT) to Strong-Buy - MarketBeat

Sep 04, 2026

Sep 03, 2026

vTv Therapeutics (VTVT) Holds Steady at $33.40 as Shares Trade FlatDiamond Pattern - vinanet.vn

Sep 03, 2026

Analysts Conflicted on These Healthcare Names: Kymera Therapeutics (KYMR) and vTv Therapeutics (VTVT) - The Globe and Mail

Sep 03, 2026

Sep 02, 2026

A type 1 diabetes drug developer plans two investor events in September - Stock Titan

Sep 02, 2026

vTv Therapeutics (NASDAQ:VTVT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat

Sep 02, 2026

Aug 31, 2026

vTv Therapeutics Inc (NASDAQ: VTVT) Share Price, VTVT Stock News, VTVT Share Price & Updates - kalkine.ca

Aug 31, 2026

Aug 26, 2026

Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - qz.com

Aug 26, 2026

Aug 19, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 19, 2026

Aug 18, 2026

vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Aug 18, 2026

Aug 15, 2026

vTv Therapeutics (VTVT) Slips 2.37% to $30.12 as Support Holds in FocusDouble Top - vinanet.vn

Aug 15, 2026

Aug 14, 2026

The Technical Signals Behind (VTVT) That Institutions Follow - news.stocktradersdaily.com

Aug 14, 2026

Aug 10, 2026

vTv Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 10, 2026

HC Wainwright Lowers Earnings Estimates for vTv Therapeutics - MarketBeat

Aug 10, 2026

Aug 09, 2026